Pharmacokinetics and -dynamics show important changes throughout childhood. Studies on the different maturational processes that influence developmental pharmacology have been used to create population PK/PD models that can yield individualized pediatric drug dosages.These models were subsequently translated to semi-physiologically or physiology-based PK (PBPK) models that support predictions in pediatric patient cohorts and other special populations. Although these translational efforts are crucial, these models should be further improved towards individual patient predictions by including knowledge on non-maturational covariates. These efforts are needed to ultimately get to systems pharmacology models for children. These models take developmental changes relating to the pediatric dynamical system into account but also other aspects that may be of importance such as abnormal body composition, pharmacogenetics, critical illness and inflammatory status.

Additional Metadata
Keywords Developmental pharmacology, Neonatology, Non-maturational covariates, Pediatrics
Persistent URL dx.doi.org/10.1016/j.ejps.2017.05.023, hdl.handle.net/1765/100233
Journal European Journal of Pharmaceutical Sciences
Citation
Allegaert, K.M, Simons, S.H, Tibboel, D, Krekels, E.H.J, Knibbe, C.A.J, & van den Anker, J.N. (2017). Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology. European Journal of Pharmaceutical Sciences. doi:10.1016/j.ejps.2017.05.023